MedTrace Logo

Markers of Recovery in StrokE Study (MORSE)

NCT03666897 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2024-02-28

No results posted yet for this study

Summary

Our current biological understanding of stroke recovery in humans is extremely limited and this lack of knowledge is a major challenge in reducing stroke disabilities and deficits. Evidence of neural repair in humans can be gleaned indirectly through functional outcome measures, but we propose that metabolomics may also provide a minimally invasive window into human brain repair. This study will integrate clinical imaging and molecular biomarkers as a diagnostic tool in further understanding stroke recovery mechanisms.

Conditions

Interventions

OTHER

DTI Images and Plasma Biomarkers

Additional Images added from standard of care MRI, Bio-markers identified

Sponsors & Collaborators

  • Georgetown University

    collaborator OTHER

  • Spectrum Health Hospitals

    lead OTHER

Principal Investigators

  • Malgorzata Miller, MD · Spectrum Health Hospital

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2022-04-01
Completion
2022-04-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03666897 on ClinicalTrials.gov